Bing Chen
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 38
- Acute Myeloid Leukemia Research 33
- Chronic Myeloid Leukemia Treatments 6
-
- Retinoids in leukemia and cellular processes 7
- Protein Degradation and Inhibitors 6
- Epigenetics and DNA Methylation 6
- Co-authors
- Sai‐Juan Chen (22 shared papers)Chen Zhu (9 shared papers)Jingyi Shi (2 shared papers)Yongmei Zhu (6 shared papers)Shu-Min Xiong (6 shared papers)Yang Shen (5 shared papers)Zhu Chen (4 shared papers)Zhixiang Shen (3 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (6 papers)Clinical Cancer Research (2 papers)Journal of Hematology & Oncology (2 papers)Acta Haematologica (2 papers)Frontiers of Medicine (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Bing Chen
58 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 106
- Hematology 781
- Genetics 240
- Cancer Research 176
- Molecular Biology 748
- Oncology 200
Countries citing papers authored by Bing Chen
This map shows the geographic impact of Bing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Chen more than expected).
Fields of papers citing papers by Bing Chen
This network shows the impact of papers produced by Bing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Chen. The network helps show where Bing Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 230 | |
| 2 | 2005 | 226 | |
| 3 | 2006 | 105 | |
| 4 | 2013 | 70 | |
| 5 | 2019 | 59 | |
| 6 | 2023 | 41 | |
| 7 | 2020 | 41 | |
| 8 | 2015 | 40 | |
| 9 | 2014 | 40 | |
| 10 | 2018 | 39 | |
| 11 | 2010 | 37 | |
| 12 | 2013 | 29 | |
| 13 | 2013 | 28 | |
| 14 | 2017 | 26 | |
| 15 | 2010 | 26 | |
| 16 | 2019 | 26 | |
| 17 | 2004 | 24 | |
| 18 | 2015 | 20 | |
| 19 | 2013 | 20 | |
| 20 | 2022 | 19 |
About Bing Chen
Bing Chen is a scholar working on Hematology, Molecular Biology, Public Health, Environmental and Occupational Health, Genetics and Oncology, having authored 59 papers that have together received 1.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (33 papers), Acute Lymphoblastic Leukemia research (11 papers), Retinoids in leukemia and cellular processes (7 papers), Protein Degradation and Inhibitors (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Epigenetics and DNA Methylation (6 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Hematology (781 citations), Genetics (240 citations), Cancer Research (176 citations), Molecular Biology (748 citations) and Oncology (200 citations). Bing Chen has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Sai‐Juan Chen, Chen Zhu, Jingyi Shi, Yongmei Zhu, Shu-Min Xiong, Yang Shen, Zhu Chen, Zhixiang Shen, Qi Cui and Yueying Wang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Clinical Cancer Research, Journal of Hematology & Oncology, Acta Haematologica and Frontiers of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.